PARP inhibitors target ATM+p53-defective gastric cancer
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Cell cycle (Georgetown, Tex.) - 13(2014), 20 vom: 10., Seite 3161-2 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Curtin, Nicola J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 19.05.2015 Date Revised 25.03.2024 published: Print CommentOn: Cell Cycle. 2014;13(13):2129-37. - PMID 24841718 Citation Status MEDLINE |
|---|
| doi: |
10.4161/15384101.2014.948787 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM244383901 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM244383901 | ||
| 003 | DE-627 | ||
| 005 | 20240325232016.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4161/15384101.2014.948787 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM244383901 | ||
| 035 | |a (NLM)25485492 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Curtin, Nicola J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PARP inhibitors target ATM+p53-defective gastric cancer |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.05.2015 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Cell Cycle. 2014;13(13):2129-37. - PMID 24841718 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Phthalazines |2 NLM | |
| 650 | 7 | |a Piperazines |2 NLM | |
| 650 | 7 | |a Poly(ADP-ribose) Polymerase Inhibitors |2 NLM | |
| 650 | 7 | |a Tumor Suppressor Protein p53 |2 NLM | |
| 650 | 7 | |a Ataxia Telangiectasia Mutated Proteins |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Cell cycle (Georgetown, Tex.) |d 2002 |g 13(2014), 20 vom: 10., Seite 3161-2 |w (DE-627)NLM122165837 |x 1551-4005 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2014 |g number:20 |g day:10 |g pages:3161-2 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4161/15384101.2014.948787 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2014 |e 20 |b 10 |h 3161-2 | ||